U.S. Markets closed

Curaleaf tumbles on FDA's CBD marketing crackdown

Curaleaf tumbled today after the FDA issued a warning to the company on its marketing efforts for its CBD oil, saying the company was making unsubstantiated health claims. Yahoo Finance's Zack Guzman and Heidi Chung are joined by Anna-Marie Wascher, Flat World Partners CEO, to discuss.